IKK-RORc-KO mice were treated between 3 weeks and 2.3 months with anti-CD8, anti-CD20 antibodies or their combination. IKK-RORc-KO mice were treated with anti-CD4 antibodies between 3 weeks and 2.3 months, or between 1.6 months and 2.3 months. To avoid a humoral response against the ...